Simnova
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- $87M
Investors
- 8
About Simnova
, dba Simnova, is a biotechnology company focusing on the development of cell therapy for cancer treatment. The company was affiliated to Simcere Group before spinning off to operate independently in 2021. In 2022, the company's first product of the allogeneic CAR-NK platform has entered clinical stage. Simnova focuses on CAR-based cell therapies (including CAR-NK and CAR-T) for cancer patients with hematologic malignancies or solid tumors. The company has developed multiple pipelines for the treatment of B-cell malignancies (SNC103), multiple myeloma (SNC112), solid tumors (SNC113, SNC115), etc. The company generates revenue from developing cell therapy for cancer treatment.
Who invested in Simnova
8 investors across 2 rounds
See all investors in Simnova
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Simnova
Who invested in Simnova?
Simnova has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Simnova raised?
Simnova has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Simnova last raise money?
Simnova's most recent round on record is a Series B, in Aug 2026.
What does Simnova do?
, dba Simnova, is a biotechnology company focusing on the development of cell therapy for cancer treatment.
Where is Simnova headquartered?
Simnova is headquartered in Shanghai, China.
Which VCs invest in companies like Simnova?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Simnova's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Simnova? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.